Ehninger,Gerhard

Institution: Medizinische Klinik und Poliklinik I, UniversitÃ¤tsklinikum Dresden, Dresden, Germany

Top Collaborators: Kramer M, Bornhäuser M, Schaich M, Röllig C, Thiede C, Schmidt AH, Stölzel F, Solloch UV, Schäfer-eckart K, Pingel J, Aulitzky W, Wachowiak J, Schetelig J, Rutt C, Illmer T, Mohr B, Schmitz N, Schuler U, Stuhlmann R, Pfirrmann M

Research Interests: Patients, Donors, Cell, Stem, Stem Cell, Acute Myeloid Leukemia, Leukemia, Myeloid Leukemia, Stem Cells, Transplantation, Donor, Blood, Human, Leukapheresis, Population, Safety, Treatment, Haplotype, Hla-drb1, Probabilities

Publications

Information and abstracts for author publications
Published Date	Impact	Publication
12/22/2011	22.6	The Lancet. Oncology Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.	Abstract
05/31/2011	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.	Abstract
04/29/2013	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.	Abstract
05/23/2011	18.4	Journal of clinical oncology : official journal of the American Society of Clinical Oncology Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.	Abstract
08/07/2009	9.9	Blood Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.	Abstract
05/20/2011	4.1	PloS one Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors.	Abstract
09/12/2013	4.1	PloS one Regional HLA differences in Poland and their effect on stem cell donor registry planning.	Abstract
04/15/2012	3.2	Transfusion Peripheral blood stem cell collection in allogeneic donors: impact of venous access.	Abstract
04/08/2011	2.8	Human immunology High-resolution human leukocyte antigen allele and haplotype frequencies of the Polish population based on 20,653 stem cell donors.	Abstract
03/22/2010	2.2	Mycoses Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia.	Abstract